Do Fertility Drugs Pose Heart Risks for Women?

About 13.4% of U.S. women of reproductive age struggle with infertility, leading many to pursue assisted reproductive technologies (ARTs) like in vitro fertilization ARTs help initiate pregnancy but raise concerns such as multiple births, high financial costs, ovarian hyperstimulation syndrome, elevated stress, and emerging evidence linking them to long-term heart disease risk A long-term study that followed women for 12 years found each additional ART cycle was associated with higher cardiovascular disease risk The increased cardiovascular risk centered on pulmonary embolism and deep vein thrombosis, showing that ART-related heart risk involves dangerous clot formation rather than gradual blood pressure or artery disease Programmed frozen embryo transfer cycles showed stronger heart disease associations, highlighting that hormone protocol choices during fertility treatment can influence long-term cardiovascular outcomes years after pregnancy